Ronald Blue & Co’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-4,254
Closed -$200K 258
2017
Q1
$200K Buy
+4,254
New +$203K 0.01% 210
2015
Q4
Sell
-11,642
Closed -$490K 258
2015
Q3
$490K Sell
11,642
-1,991
-15% -$93K 0.03% 151
2015
Q2
$680K Buy
13,633
+1,265
+10% +$59.9K 0.03% 123
2015
Q1
$557K Buy
12,368
+126
+1% +$5.66K 0.03% 152
2014
Q4
$590K Buy
12,242
+353
+3% +$16.8K 0.03% 144
2014
Q3
$569K Buy
11,889
+249
+2% +$12.1K 0.04% 142
2014
Q2
$576K Buy
11,640
+1,015
+10% +$47.5K 0.04% 152
2014
Q1
$500K Sell
10,625
-67
-0.6% -$3.08K 0.04% 152
2013
Q4
$514K Buy
10,692
+1,478
+16% +$66.3K 0.04% 147
2013
Q3
$385K Buy
9,214
+9,047
+5,417% +$390K 0.03% 162
2013
Q2
$7K Buy
+167
New +$6.14K ﹤0.01% 231

Other funds holding MET

Ronald Blue & Co's MET Position: Q2 2017 in Review

Ronald Blue & Co sold out of MetLife (MET) in Q2 2017, closing a stake of 4,254 shares — an estimated $200K sold.

Ronald Blue & Co first reported a position in MET in Q2 2013 and held it in 11 quarters. The position peaked at $680K in Q2 2015. 1,030 funds tracked by Wall St. Rank hold MET as of Q2 2017.

  • Ronald Blue & Co reported no remaining MetLife position as of Q2 2017 after selling out during the quarter.
  • Ronald Blue & Co sold 4,254 MetLife shares in Q2 2017, an estimated $200K.
  • Ronald Blue & Co first reported a position in MetLife in Q2 2013 and held it in 11 quarters.
  • Ronald Blue & Co's MetLife position peaked at $680K in Q2 2015.
  • 1,030 funds tracked by Wall St. Rank held MetLife as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.